CLINICAL_TRIALS
trial_result
· 2024-09-19
Clinical Trial Update: A Study to Learn About Abrocitinib Tablets in People With Atopic Dermatitis in India [Phase 3]
Summary
A Phase 3 study evaluating abrocitinib tablets for atopic dermatitis in India has completed, and the trial results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Atopic Dermatitis | Phase 3 | Status: COMPLETED | Results posted: 2024-09-19